Clinical Trial Update: Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating artemisinin-based combination therapy (ACT) plus primaquine for uncomplicated Plasmodium vivax malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Artemisinin-based combination therapy (ACT)
• Primaquine (primaquine)

Snippet

Sponsor: University of Oxford | Conditions: Vivax Malaria | Phase 3 | Status: COMPLETED